494 related articles for article (PubMed ID: 23664268)
1. Serum levels of brain-derived neurotrophic factor are unchanged after transcranial direct current stimulation in treatment-resistant depression.
Palm U; Fintescu Z; Obermeier M; Schiller C; Reisinger E; Keeser D; Pogarell O; Bondy B; Zill P; Padberg F
J Affect Disord; 2013 Sep; 150(2):659-63. PubMed ID: 23664268
[TBL] [Abstract][Full Text] [Related]
2. BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: results from a factorial, randomized, sham-controlled trial.
Brunoni AR; Machado-Vieira R; Zarate CA; Vieira EL; Vanderhasselt MA; Nitsche MA; Valiengo L; Benseñor IM; Lotufo PA; Gattaz WF; Teixeira AL
Eur Neuropsychopharmacol; 2014 Jul; 24(7):1144-51. PubMed ID: 24702987
[TBL] [Abstract][Full Text] [Related]
3. International randomized-controlled trial of transcranial Direct Current Stimulation in depression.
Loo CK; Husain MM; McDonald WM; Aaronson S; O'Reardon JP; Alonzo A; Weickert CS; Martin DM; McClintock SM; Mohan A; Lisanby SH;
Brain Stimul; 2018; 11(1):125-133. PubMed ID: 29111077
[TBL] [Abstract][Full Text] [Related]
4. BDNF blood levels after non-invasive brain stimulation interventions in major depressive disorder: a systematic review and meta-analysis.
Brunoni AR; Baeken C; Machado-Vieira R; Gattaz WF; Vanderhasselt MA
World J Biol Psychiatry; 2015 Feb; 16(2):114-22. PubMed ID: 25264290
[TBL] [Abstract][Full Text] [Related]
5. Increase in PAS-induced neuroplasticity after a treatment course of transcranial direct current stimulation for depression.
Player MJ; Taylor JL; Weickert CS; Alonzo A; Sachdev PS; Martin D; Mitchell PB; Loo CK
J Affect Disord; 2014; 167():140-7. PubMed ID: 24968188
[TBL] [Abstract][Full Text] [Related]
6. PsychotherapyPlus: augmentation of cognitive behavioral therapy (CBT) with prefrontal transcranial direct current stimulation (tDCS) in major depressive disorder-study design and methodology of a multicenter double-blind randomized placebo-controlled trial.
Bajbouj M; Aust S; Spies J; Herrera-Melendez AL; Mayer SV; Peters M; Plewnia C; Fallgatter AJ; Frase L; Normann C; Behler N; Wulf L; Brakemeier EL; Padberg F
Eur Arch Psychiatry Clin Neurosci; 2018 Dec; 268(8):797-808. PubMed ID: 29214483
[TBL] [Abstract][Full Text] [Related]
7. Prelimbic Stimulation Ameliorates Depressive-Like Behaviors and Increases Regional BDNF Expression in a Novel Drug-Resistant Animal Model of Depression.
Moshe H; Gal R; Barnea-Ygael N; Gulevsky T; Alyagon U; Zangen A
Brain Stimul; 2016; 9(2):243-50. PubMed ID: 26655599
[TBL] [Abstract][Full Text] [Related]
8. Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients.
Zanardini R; Gazzoli A; Ventriglia M; Perez J; Bignotti S; Rossini PM; Gennarelli M; Bocchio-Chiavetto L
J Affect Disord; 2006 Mar; 91(1):83-6. PubMed ID: 16448701
[TBL] [Abstract][Full Text] [Related]
9. Effects of electroconvulsive therapy on serum levels of brain-derived neurotrophic factor and nerve growth factor in treatment resistant major depression.
Bilgen AE; Bozkurt Zincir S; Zincir S; Ozdemir B; Ak M; Aydemir E; Sener I
Brain Res Bull; 2014 May; 104():82-7. PubMed ID: 24747833
[TBL] [Abstract][Full Text] [Related]
10. BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy.
Kleimann A; Kotsiari A; Sperling W; Gröschl M; Heberlein A; Kahl KG; Hillemacher T; Bleich S; Kornhuber J; Frieling H
J Neural Transm (Vienna); 2015 Jun; 122(6):925-8. PubMed ID: 25387785
[TBL] [Abstract][Full Text] [Related]
11. Brain-derived neurotrophic factor serum concentrations in depressive patients during vagus nerve stimulation and repetitive transcranial magnetic stimulation.
Lang UE; Bajbouj M; Gallinat J; Hellweg R
Psychopharmacology (Berl); 2006 Jul; 187(1):56-9. PubMed ID: 16767416
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor serum concentrations in acute depressive patients increase during lithium augmentation of antidepressants.
Ricken R; Adli M; Lange C; Krusche E; Stamm TJ; Gaus S; Koehler S; Nase S; Bschor T; Richter C; Steinacher B; Heinz A; Rapp MA; Borgwardt S; Hellweg R; Lang UE
J Clin Psychopharmacol; 2013 Dec; 33(6):806-9. PubMed ID: 24018547
[TBL] [Abstract][Full Text] [Related]
13. Transcranial direct current stimulation in treatment resistant depression: a randomized double-blind, placebo-controlled study.
Palm U; Schiller C; Fintescu Z; Obermeier M; Keeser D; Reisinger E; Pogarell O; Nitsche MA; Möller HJ; Padberg F
Brain Stimul; 2012 Jul; 5(3):242-251. PubMed ID: 21962978
[TBL] [Abstract][Full Text] [Related]
14. Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system.
Brunoni AR; Kemp AH; Shiozawa P; Cordeiro Q; Valiengo LC; Goulart AC; Coprerski B; Lotufo PA; Brunoni D; Perez AB; Fregni F; Benseñor IM
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1530-40. PubMed ID: 23615118
[TBL] [Abstract][Full Text] [Related]
15. Fronto-extracephalic transcranial direct current stimulation as a treatment for major depression: an open-label pilot study.
Martin DM; Alonzo A; Mitchell PB; Sachdev P; Gálvez V; Loo CK
J Affect Disord; 2011 Nov; 134(1-3):459-63. PubMed ID: 21641047
[TBL] [Abstract][Full Text] [Related]
16. Electroconvulsive therapy improves clinical manifestation with plasma BDNF levels unchanged in treatment-resistant depression patients.
Lin CH; Chen MC; Lee WK; Chen CC; Huang CH; Lane HY
Neuropsychobiology; 2013; 68(2):110-5. PubMed ID: 23881232
[TBL] [Abstract][Full Text] [Related]
17. Interactions between transcranial direct current stimulation (tDCS) and pharmacological interventions in the Major Depressive Episode: findings from a naturalistic study.
Brunoni AR; Ferrucci R; Bortolomasi M; Scelzo E; Boggio PS; Fregni F; Dell'Osso B; Giacopuzzi M; Altamura AC; Priori A
Eur Psychiatry; 2013 Aug; 28(6):356-61. PubMed ID: 23182847
[TBL] [Abstract][Full Text] [Related]
18. Pre-treatment attentional processing speed and antidepressant response to transcranial direct current stimulation: Results from an international randomized controlled trial.
Martin DM; McClintock SM; Aaronson ST; Alonzo A; Husain MM; Lisanby SH; McDonald WM; Mohan A; Nikolin S; O'Reardon J; Weickert CS; Loo CK
Brain Stimul; 2018; 11(6):1282-1290. PubMed ID: 30172724
[TBL] [Abstract][Full Text] [Related]
19. Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): an exploratory analysis.
Brunoni AR; Machado-Vieira R; Zarate CA; Vieira EL; Valiengo L; Benseñor IM; Lotufo PA; Gattaz WF; Teixeira AL
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():91-6. PubMed ID: 25172025
[TBL] [Abstract][Full Text] [Related]
20. Both Serum Brain-Derived Neurotrophic Factor and Interleukin-6 Levels Are Not Associated with Therapeutic Response to Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder.
Kagawa S; Mihara K; Suzuki T; Nagai G; Nakamura A; Nemoto K; Kondo T
Neuropsychobiology; 2017; 75(3):145-150. PubMed ID: 29332095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
